Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 3Plasma cell 2Other hematologic neoplasm 2Lymphoid 2Sarcoma 1Other 1Gastrointestinal 1

Conditions

Mucositis 6Head and Neck Neoplasms 3Neoplasms 2Xerostomia 1Stomatitis 1Squamous Cell Carcinoma of Head and Neck 1Radiation Injuries 1Pain 1Oral Ulcer 1Multiple Myeloma 1Leukemia 1Laryngeal Diseases 1Drug-Related Side Effects and Adverse Reactions 1Carcinoma, Squamous Cell 1

Interventions

Injections 3aluminum hydroxide, magnesium hydroxide, drug combination 2Xylitol 2Water 2Radiotherapy 2RRx-001 2Propolis 2Low-Level Light Therapy 2Lidocaine 2Honey 2Diphenhydramine 2Cisplatin 2peppermint oil 1hydrated silica gel-based toothpaste 1golotimod 1calcium phosphate 1brilacidin 1anise oil 1amlexanox 1Traumeel S 1Sorbic Acid 1Sodium Chloride 1Sodium Bicarbonate 1Radiotherapy, Intensity-Modulated 1Poloxamer 1Phosphatidylinositol 3-Kinases 1Glycerol 1Glutamine 1Folic Acid 1Fibroblast Growth Factor 7 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Stomatitis × Fibroblast Growth Factor 7 × Other × Clear all
NCT00101582 2016-09-27

Palifermin for the Reduction of Oral Mucositis in Patients With Locally Advanced Head and Neck Cancer

Swedish Orphan Biovitrum

Phase 3 Completed
188 enrolled 19 charts
Head & NeckOther

Carcinoma, Squamous Cell, Head and Neck Neoplasms, Laryngeal Diseases, Stomatitis, Xerostomia, Oral Ulcer, Mucositis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡